Introduction: The tick-borne disease Lyme Borreliosis is caused by Borrelia bacteria. The disease can persist even after treatment with antibiotics, which is why other methods of treatment are needed. Herbal compounds and phytochemicals have been recently examined in relation to eradicating Borrelia bacteria in vitro.
Introduction
The spirochete bacteria Borrelia burgdorferi, found in Ixodes ticks, is the causative agent for Lyme Borreliosis [1] . Unfavorable conditions, such as changes in pH, nutritional depletion, even antibiotics can lead the pleomorphic bacteria to reversibly alter their form into Round Bodies (RBs) or biofilms [2, 3] . Furthermore, the immune system reacts differently to the pleomorphic forms with macrophages digesting and processing RBs differently than spirochetes [4] . Hence, examinations of B. burgdorferi need to include these various forms.
Borrelia infected patients report signs and symptoms ranging from skin inflammation, arthritis and neurological or cardiac impairments [5] . Treatment with antibiotics early on the infection can clear the pathogen from the body, however, post-treatment persistence by the bacteria as asymptomatic or with a multiplicity of symptoms can occur [5] . It has been suggested that the different pleomorphic forms of Borrelia are involved in the avoidance of the immune system, and thus, in the persistence of the disease [6] .
Current treatment for Lyme borreliosis relies solely on antibiotics [5] . However, studies on antibiotic efficiency with different pleomorphic forms of Borrelia have shown to demonstrate varying effectiveness of antibiotics in killing the bacteria [6, 7] . Therefore, new approaches for better treatment are required.
For centuries herbal compounds have been used as remedies for various ailments. Recently, the antimicrobial possibilities of a variety of phytochemicals and herbal extracts against Borrelia have been studied [8] [9] [10] . Hence, studies on natural composites might offer new possibilities for remedies to Lyme Borreliosis. Here, two commercially available herbal compounds, Biocidin Liquid and LSF Broad-Spectrum Liposomal formulas, were tested for their efficiency in eliminating different pleomorphic forms of B. burgdorferi in vitro.
Materials and methods

Bacterial strain, culturing conditions and test compounds
All experiments were conducted with infectious, fluorescent B. burgdorferi strain GCB726 with GFP, which was graciously provided by Georges Chaconas, University of Calgary, Canada [11] . BarbourStoenner-Kelly medium (BSK II) [12] , without gelatin and supplemented with 6% heat inactivated rabbit serum (Sigma-Aldrich, St. Louis, USA) was used in the culturing of cells at +37 ºC. Low-passage number cells (≤ passage 8) were used in all of the experiments.
The tested compounds, Biocidin ® Liquid formula and Biocidin ® LSF Broad-Spectrum Liposomal formula, were acquired from Bio-Botanical Research Inc. (CA, USA). As negative controls for growth 100 µg/ml of doxycycline (Hexal ® , Germany) and 0.02 % H 2 O 2 (Sigma-Aldrich) were used. Untreated cells were a positive control for growth.
Minimum inhibitory concentration and minimum bacterial death experiments
The minimum inhibitory concentrations (MICs) of Biocidin ® Liquid and Liposomal formulas were determined by incubating 15 x 10 6 B. burgdorferi spirochetes in 3 ml of culture media with different dilutions (1:5, 1:10, 1:25 and 1:50) of the compounds for 96 h [13] . The samples were measured for fluorescence with a spectrophotometer (Perkin Elmer, 2030 Multilabel reader Victor ™ x4) every 24 h.
RBs were induced as previously described [13] . Briefly, 15 x 10 6 B. burgdorferi spirochetes were incubated in sterile distilled H 2 O at +37 °C for 2 h before placing the cells into 3 ml of fresh media and adding the same dilutions of each Biocidin ® compound as with the spirochete samples. Fluorescence measurements were done in the above-mentioned manner.
The MICs for both compounds with biofilms were determined by counting a 10 µl area in a C-Chip DHC-N01 Disposable Haemocytometer (System Neubauer Improved, Digital Bio) at 0 h and 72 h post-treatment. Approximately 9000 biofilms in 3 ml of fresh media were treated the previously mentioned dilutions of Biocidin ® compounds and incubated at +37 °C for 72 h after which the samples were counted. Cell clusters of over 10 cells were regarded as biofilms.
The minimum bacterial death (MBD) were determined as has been done previously with alterations [13] . Samples of 300 μl from the MIC experiments from each pleomorphic form from the 72-h time point, respectively, were reseeded into 3 ml of fresh media and incubated for 3 weeks at +37 °C. At weeks 1 and 3 the change in pH (color change) of the media was used to indicate growth (yes/no) and microscopy (Leica CTR5500, Germany) was utilized at week 3 to confirm the observations.
Time-kill experiments
The rate of cell death of B. burgdorferi was analyzed by adding the MIC dilutions of the compounds (Liquid formula = 1:10; Liposomal formula = 1:25) to 6 x 10 6 spirochetes in 3 ml of culture media and counting the cells using a C-Chip haemocytometer at 10, 20, 30, 60-and 120-min post-treatment. The means of three separate experiments were counted and Excel was used in producing the graph.
Results
MIC and MBD experiments
The MICs for Biocidin ® Liquid and Liposomal formulas with spirochetes, RBs and biofilms of B. burgdorferi were determined ( Figure  1) . The MICs for both compounds with each B. burgdorferi form in Figure 1 are highlighted with a black star. First, the MIC for the Liquid formula with spirochetes demonstrated 1:10 dilution ( Figure 1A ), while 1:25 dilution was enough with the Liposomal formula ( Figure 1B ), as these were the lowest dilutions at which no growth was observed. Second, the MICs for both formulas with RBs was determined to be the 1:50 dilution ( Figure 1C and 1D) , as the relative fluorescence values followed those of the negative controls. Last, the MICs of both formulas with biofilms were deduced by counting the biofilms in 10 μl of each sample. Both compounds demonstrated an MIC of 1:10 dilution when cultured with biofilms ( Figure 1E ).
At 72 h time point of the MIC experiments, samples were put to fresh media and incubated for three weeks with the purpose of determining the MBDs for both compound with each B. burgdorferi pleomorphic form. Below table exemplifies the results from two separate experiments for each B. burgdorferi form (Table 1) . Firstly, the Liquid formula demonstrated no growth with the 1:5 dilution during the whole threeweek time period in all of the bacterial forms. On the third week growth was observed in each pleomorphic form with the 1:10, 1:25 and 1:50 dilutions except the 1:10 dilution in RBs. Moreover, both spirochete and biofilm samples had growth with the 1:25 and 1:50 dilutions already at week one, while the RB samples showed none. Hence, the short-term dilutions of the Liquid formula for each pleomorphic form correlated those of the MIC results. However, only the 1:5 dilution resulted in no growth long-term with all pleomorphic forms.
Secondly, the results for the Liposomal formula followed those of the Liquid formula, although most of the spirochete samples have been examined only once and the third week of 1:10 dilution with RBs is completely missing because of inapplicable data. However, similarly to the Liquid formula, the Liposomal formula demonstrated no growth in the 1:5 dilution with each of the pleomorphic form. Furthermore, both spirochetes and biofilms indicated growth at week one already in the 1:25 and 1:50 dilutions, while RBs expressed no growth at week one in any of the dilutions. The first week MBD results for the Liposomal formula with RBs and biofilms corresponded to the MIC results. However, when cultured with spirochetes the 1:25 dilution already indicated growth at week one. Thus, contradicting the MIC for the Liposomal formula determined earlier.
Time-kill experiments
The effectiveness of the Biocidin ® compounds on B. burgdorferi spirochetes was determined in time-kill experiments (Figure 2) . B. burgdorferi spirochetes were treated with the MICs of the compounds: 1:10 dilution for the Liquid formula; 1:25 for the Liposomal formula, and the cells were counted at 10, 20, 30, 60-and 120-min posttreatment. Both compounds induced cell death of B. burgdorferi, with the Liquid formula being slightly more effective.
Discussion
Lyme borreliosis is currently the most common tick-borne disease in the Northern hemisphere (Stanek et al. 2012) [14] . Antibiotics are usually effective against Borrelia sp., however, persisting forms have been uncovered capable of resisting certain antibiotics [6, 15] . Therefore, investigating novel possibilities for eliminating the persisting bacteria from the body is crucial. Here two dietary supplement compounds from Bio-Botanical Research Inc. were examined for their ability to eradicate the different pleomorphic forms of B. burgdorferi in vitro.
In recent years, the effects of several phytochemicals on Borrelia have been studied and found to be effective against the different pleomorphic forms of the bacteria [8] [9] [10] [16] [17] [18] . For instance, Stevia whole leaf extract has been found to reduce the size and number of Borrelia biofilms [10] . Additionally, grapefruit seed extract has been demonstrated to work against Borrelia spirochetes and RBs [16] . Recently though, oregano oil was found to be highly active against persistent (7day growth) forms of Borrelia even at low concentrations [17] . Similarly, to previous studies, both of the compounds used here diminished the growth of all B. burgdorferi forms as was demonstrated by the MIC and MBD experiments. The active ingredients in both compounds vary from berry extracts to essential oils from plants. Interestingly, both of the compounds used here also have oregano oil, as well as, grapefruit seed extract as active agents in them.
Additionally, the number of spirochetes were drastically reduced after only 2 h post-treatment with the Biocidin ® compounds. This suggests that these compounds could offer a possible treatment for Lyme borreliosis, if not solely on their own but possibly when used synergistically with antibiotics as has been done before with other phytochemicals [19] . Naturally, studies involving antibiotics, as well as, RBs and biofilms should be conducted in order to realize the full potential of these compounds. Still, the promising results gained here for these two compounds indicate new possibilities to combat B. burgdorferi infections.
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